ORAMED PHARMACEUTICALS INC (ORMP)
US68403P2039 - Common Stock
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the fourth quart...
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Oramed Letter to Shareholders
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...
PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization
/PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has...
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
/PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving...
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex")...
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com) announced today that it has signed a non-binding term sheet with Hefei...
Oramed to Present at the 83rd American Diabetes Association Conference
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it has been selected to present an oral abstract...
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will...
Oramed's Chinese partner HTIT completes phase 3 oral insulin trial (NASDAQ:ORMP)
Oramed Pharmaceuticals (ORMP) has announced the successful completion of Phase 3 trials for oral insulin in type 2 diabetes in China by its strategic partner, Hefei Tianhui...
Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com) announced today that Hefei Tianhui Biotechnology Co. Ltd. (HTIT), a...
Investing millions, Ben Shapiro joins board of Oramed Pharmaceuticals
Conservative political commentator and entrepreneur, Ben Shapiro, has taken a $4.7M stake in struggling Israeli pharmaceutical company Oramed Pharmaceuticals. Read more here.
Conservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Company
Right-wing media entrepreneur Ben Shapiro has taken a $4.7 million stake in a struggling Israeli pharmaceutical company and joined the board.
Top Buys by Directors: Kidron's $254K Bet on ORMP
Top Buys by Top Brass: CEO Kidron's $254K Bet on ORMP
Oramed Pharmaceuticals Issues Shareholder Update
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it continues to conduct a comprehensive analysis...
Hot Stocks: CTSH rises on guidance; LOGI slumps; CAT hits 52-week high; ORMP plunges 76%
CAT set a 52-week high. CTSH rose on guidance and a leadership change. LOGI falls on a weak forecast. ORMP plunged 76% on clinical data.
Why Oramed Pharmaceuticals Stock Is Crashing Today
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.
AVCT Stock Falls as American Virtual Cloud Technologies Files for Bankruptcy
American Virtual Cloud Technologies (AVCT) stock is taking a beating on Thursday as the company, and two subsidiaries, file for bankruptcy.
Why Is Oramed (ORMP) Stock Down 75% Today?
Oramed (ORMP) stock is falling hard Thursday after announcing a Phase 3 clinical trial of its diabetes treatment missed its primary endpoint.